核素运动心肌灌注断层显像评估经皮冠状动脉腔内血管成形术的疗效

首都医科大学学报 ›› 1994, Vol. 15 ›› Issue (2): 133-135.

核素运动心肌灌注断层显像评估经皮冠状动脉腔内血管成形术的疗效

那开宪¹, 余平², Ang ES³, Tan ATH⁴

1. 首都医学院附属北京友谊医院心内科;2. 北京急救中心;3. 新加坡中央医院核医学科;4. 新加坡中央医院心脏科

收稿日期:1993-02-13 修回日期:1900-01-01 出版日期:1994-04-15 发布日期:1994-04-15

Evaluation of the PTCA Effect by Tomography Imaging of Exercise Stress Myocardial Nuclide-Perfusion

Na Kaixian¹, Yu Ping², Ang ES³, Tan ATH⁴

1. Beijing Friendship Hospital, Capital Institute of Medicine;2. Beijing Emergency Medical Centre;3. Singapore General Hospital

Received:1993-02-13 Revised:1900-01-01 Online:1994-04-15 Published:1994-04-15

摘要/Abstract

摘要： 总结了31例经皮冠状动脉腔内血管成形术(PTCA)前后作核素运动心肌灌注断层显像的病例,其中男性25例,女性6例.PTCA前冠状动脉平均狭窄82.58%±16.04%,术后为17.7%±6.21%.运动心肌灌注断层显像显示PTCA术后心肌缺血完全消失及明显改善26例(83.9%).90.3%的病例PTCA术后运动试验较术前进步.认为运动心肌灌注断层显像可作为判断PTCA疗效的有效方法.

关键词: 运动心肌灌注断层显像, 经皮冠状动脉腔内血管成形术, 冠心病

Abstract: We performed stress and rest myocardial perfusion tomography imaging in 31 patients before and after percutaneous transluminal coronary angioplasty(PTCA). The median time intervals before and after PTCA were 7.5 and 47.5 days respectively. There were 25 males and 6 females. Mean lesion grade pre-PTCA was 82.58%±16.04 % and mean residual lesion grade post-PTCA was 17.7%±6.21%. No major complications were encountered. Myocardial perfusion tomography imaging showed 26 cases with myocardial ischemia reverted to normal or approximately normal after PTCA. In 90.3% of the patients exercise stress was more improved than before PTCA.We conclude that exercise stress myocardial tomography imaging is a noninvasive and reliable method for the assesssment of PTCA therapeutic effect.

Key words: myocardial nuclide perfusion, PTCA, coronary heart disease

中图分类号:

R541.4

那开宪;余平;Ang ES;Tan ATH. 核素运动心肌灌注断层显像评估经皮冠状动脉腔内血管成形术的疗效[J]. 首都医科大学学报, 1994, 15(2): 133-135.

Na Kaixian;Yu Ping;Ang ES;Tan ATH. Evaluation of the PTCA Effect by Tomography Imaging of Exercise Stress Myocardial Nuclide-Perfusion[J]. Journal of Capital Medical University, 1994, 15(2): 133-135.

[1]	苏云娟, 王京京, 韩晓涛, 刘海燕, 陈永福, 杨柳, 吴其明. 青年男性冠心病的危险因素及Framingham风险评分的预测价值[J]. 首都医科大学学报, 2022, 43(1): 143-148.
[2]	谷珊珊, 王蒨, 董薇, 焦建, 苏航, 付瑛. 心脏融合显像定量评价功能相关冠状动脉狭窄的临床研究[J]. 首都医科大学学报, 2013, 34(1): 36-42.
[3]	南楠;金泽宁;杨泽. 脂联素基因多态性与2型糖尿病合并冠心病的关联研究[J]. 首都医科大学学报, 2012, 33(4): 421-426.
[4]	高敬;华琦;王彩荣;李晓辉;高承梅. 实时三维超声心动图评价冠心病患者左心功能[J]. 首都医科大学学报, 2008, 29(4): 487-489.
[5]	王珊;谭静;华琦. 辛伐他汀对稳定性冠心病患者的血清高敏C-反应蛋白水平的影响[J]. 首都医科大学学报, 2008, 29(4): 490-492.
[6]	陈可冀;薛梅;殷惠军. 血小板活化与冠状动脉粥样硬化性心脏病和血瘀证的关系[J]. 首都医科大学学报, 2008, 29(3): 266-269.
[7]	杨毅;袁申元;潘素芳;钱宁. 体质量指数与糖尿病、冠心病、脑卒中发病率的相关性[J]. 首都医科大学学报, 2006, 27(5): 669-671.
[8]	赵秀丽;周延明;杨金奎;李金城;张慧;吴莹;张仁汉;胡大一. 格列吡嗪控释片治疗冠心病合并2型糖尿病的临床研究[J]. 首都医科大学学报, 2006, 27(1): 78-80.
[9]	陈欣;杨明;邹凤军;丁五麟;张小航;王青;高亢;潘国忠;尹朝霞;韩凌;胡文泽;岑强. 腺苷超声心动图负荷试验诊断冠心病的应用价值[J]. 首都医科大学学报, 2005, 26(2): 136-139.
[10]	张雪莲;傅汉菁;潘素芳. 糖尿病慢性大血管并发症与vWF的关系[J]. 首都医科大学学报, 2004, 25(4): 488-492.
[11]	王旭东;樊峥;傅研;殷红;翟艳玲;祁雅慧;朱宇清;王瑾;赵相印. 2型糖尿病合并冠心病患者纤溶酶原激动抑制剂-1基因多态性分析[J]. 首都医科大学学报, 2004, 25(2): 223-226.
[12]	王青;胡大一;王杰平;尹朝霞. 糖化低密度脂蛋白与冠心病相关性的研究[J]. 首都医科大学学报, 2003, 24(1): 47-50.
[13]	傅研;王旭东;翟艳玲;樊峥;杨玲;朱宇清;祁雅慧;赵相印. 纤溶酶原激动抑制剂-1基因4G/5G多态性与冠心病[J]. 首都医科大学学报, 2001, 22(2): 119-122.
[14]	徐晓薇;杜凤和;张春玲. 叶酸治疗高半胱氨酸血症30例临床观察[J]. 首都医科大学学报, 2001, 22(1): 48-49.
[15]	屈正;张兆光;于建波;叶建光;孙衍庆;马临安;徐屹. 高龄高危患者激光心肌血运重建术[J]. 首都医科大学学报, 2000, 21(3): 198-200.